DUBLIN, June 1, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced that Ken Washington, Ph.D., has been appointed Medtronic Chief Technology and Innovation Officer. In this newly created role, Dr. Washington will leverage his extensive experience leading technology development and execution across industries including robotics, consumer products, automotive, and space, to accelerate innovation-driven […]
Other News
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2023 that were approved by the Compensation Committee of its Board of […]
Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, announced it has received a grant from the Israel Innovation Authority (“IIA”) in the amount of NIS 1.62 million, which based on a […]
Gradient Denervation Technologies Enrolls Initial Patient in First-In-Human Study of Pulmonary Artery Denervation Technology
Company plans Early Feasibility Study in the US for late 2023 PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients with associated pulmonary hypertension, announced today the successful first patient enrollment in its […]
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (≥ 500 mg/dL) — — EddingPharm Now Working Towards Preparing for Commercial Launch of VASCEPA Across Mainland China Expected by Year-End — DUBLIN, Ireland and BRIDGEWATER, […]
Methodist Le Bonheur Healthcare’s Olive Branch Hospital is Among Nation’s Top Performing Hospitals for Treatment of Heart Attack Patients
American College of Cardiology recognizes sustained, high-level performance in quality of care MEMPHIS, Tenn., June 1, 2023 /PRNewswire/ — The American College of Cardiology recognizes Methodist Le Bonheur Healthcare‘s Olive Branch Hospital for its dedication and excellence in treating heart attack patients. Methodist Olive Branch Hospital received the National Cardiovascular Data Registry Chest Pain – […]
Distinguished Cardiac Surgeon Dr. Abbas Ardehali Joins Medcura’s Board of Directors
RIVERDALE, Md., June 1, 2023 /PRNewswire/ — Medcura Inc. welcomes Dr. Abbas Ardehali to its Board of Directors. Dr. Ardehali is a professor of surgery and medicine in the division of cardiothoracic surgery at the David Geffen School of Medicine at UCLA. Dr. Ardehali also serves as director of the UCLA Heart and […]
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Lightning Bolt™ 7 is the most advanced arterial thrombectomy system on the market Latest technology combines modulated aspiration with superior catheter design to maximize blood clot removal in a single session ALAMEDA, Calif., June 1, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the U.S. Food […]
Fluid Biomed Inc. Announces World’s First Implantation of Polymer-based Neurovascular Stent in Human Patients
First-in-Human Clinical Safety Trial is Successfully Launched using ReSolv™, the Unique Polymer-Based Flow-Diverting Stent Designed to Treat Brain Aneurysms Company Advisory Board Expands to Include Respected Medical Key Opinion Leader and Medtech Entrepreneur CALGARY, AB, June 1, 2023 /PRNewswire/ – Fluid Biomed Inc., a medical device company developing ReSolv™, the world’s first hybrid […]
Esperion Announces Submission of Supplemental New Drug Applications to U.S. FDA for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet
– Submitted four efficacy supplements seeking inclusion of CV risk reduction and expansion of LDL-C lowering – – Anticipated approvals in U.S. in the first half of 2024 – ANN ARBOR, Mich., June 01, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that it has submitted Supplemental New Drug Applications (sNDA) to […]



